(LXRX) Lexicon - Performance -46.1% in 12m
LXRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-60.88%
#87 in Peer-Group
Rel. Strength
10.06%
#6903 in Stock-Universe
Total Return 12m
-46.05%
#128 in Peer-Group
Total Return 5y
-52.83%
#66 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 2.39 USD |
| 52 Week Low | 0.29 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 84.94 |
| Buy/Sell Signal +-5 | -0.53 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: LXRX (-46.1%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: LXRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for LXRX
| Total Return (including Dividends) | LXRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 36.29% | 3.36% | 5.25% |
| 3 Months | 115.09% | 15.73% | 24.13% |
| 12 Months | -46.05% | -7.02% | 14.15% |
| 5 Years | -52.83% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | LXRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 79.5% | 4.4% | 81% |
| 3 Months | 74.4% | 78.8% | 96.9% |
| 12 Months | -80.8% | -85.8% | 44.9% |
| 5 Years | -63% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th93.00 | 31.86% | 29.49% |
| 3 Month | %th96.50 | 85.85% | 73.28% |
| 12 Month | %th36.00 | -41.97% | -52.74% |
| 5 Years | %th67.50 | -37.76% | -77.73% |
FAQs
Does Lexicon (LXRX) outperform the market?
No,
over the last 12 months LXRX made -46.05%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months LXRX made 115.09%, while XBI made 15.73%.
Performance Comparison LXRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
LXRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.1% | 31% | -7.1% | -60% |
| US NASDAQ 100 | QQQ | 8.3% | 31% | -7.8% | -59% |
| German DAX 40 | DAX | 10.2% | 37.7% | -19.3% | -75% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.2% | 33.1% | -10.5% | -66% |
| Hongkong Hang Seng | HSI | 8.5% | 30.2% | -26.6% | -85% |
| India NIFTY 50 | INDA | 9.9% | 32.8% | -7.4% | -45% |
| Brasil Bovespa | EWZ | 5.6% | 27.5% | -32.2% | -56% |
LXRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.4% | 30.4% | -11.2% | -71% |
| Consumer Discretionary | XLY | 8.6% | 33.1% | 0.5% | -64% |
| Consumer Staples | XLP | 7.7% | 35.7% | -8.8% | -55% |
| Energy | XLE | 7.7% | 29.2% | -3% | -46% |
| Financial | XLF | 7.4% | 31.2% | -12% | -76% |
| Health Care | XLV | 8.6% | 34.2% | 0.2% | -41% |
| Industrial | XLI | 8% | 32.1% | -15% | -71% |
| Materials | XLB | 5.8% | 32% | -11.6% | -52% |
| Real Estate | XLRE | 8.1% | 35.3% | -6.8% | -59% |
| Technology | XLK | 7.3% | 27.6% | -9.4% | -57% |
| Utilities | XLU | 9.1% | 34.5% | -10.3% | -69% |
| Aerospace & Defense | XAR | 10.2% | 29.2% | -25.7% | -95% |
| Biotech | XBI | 7.1% | 32.9% | 6.1% | -39% |
| Homebuilder | XHB | 5.6% | 29.3% | 0.1% | -52% |
| Retail | XRT | 5.5% | 31.3% | -2.8% | -57% |
LXRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.2% | 27.9% | 1.28% | -39% |
| Natural Gas | UNG | 17.6% | 46.1% | 9.7% | -44% |
| Gold | GLD | 7.8% | 37.5% | -27.8% | -85% |
| Silver | SLV | 7% | 29.4% | -24.5% | -64% |
| Copper | CPER | 9% | 31.7% | -24.2% | -57% |
LXRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.9% | 35.2% | -3.7% | -44% |
| iShares High Yield Corp. Bond | HYG | 9.3% | 34.7% | -6% | -56% |